Procter & Gamble, Johnson & Johnson Among 9 Companies To Announce Dividend Increases In The First Half Of AprilSeeking Alpha • 03/29/26
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once‑daily pill for plaque psoriasisPRNewsWire • 03/28/26
Can New Drugs Drive J&J's Innovative Medicine Despite Stelara LOE?Zacks Investment Research • 03/27/26
Johnson & Johnson's DARZALEX® (daratumumab) becomes the first oncology injectable approved for administration by patients or caregiversGlobeNewsWire • 03/27/26
Cancer Stocks to Buy as Innovation Reshapes Global Oncology MarketZacks Investment Research • 03/26/26
J&J's Pipeline Surge Sets Up Stronger Growth From New Drugs in 2026Zacks Investment Research • 03/26/26
Johnson & Johnson: Deserves A Place In Conservative Dividend Growth PortfoliosSeeking Alpha • 03/26/26
Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth KnowingZacks Investment Research • 03/25/26
J&J Stock Trading Above 200- & 50-Day SMA for 8 Months: Time to Buy?Zacks Investment Research • 03/24/26
Brokers Suggest Investing in Johnson & Johnson (JNJ): Read This Before Placing a BetZacks Investment Research • 03/24/26